Find out what Breast Cancer Care is saying about the latest drug treatments, research papers and health policy issues.

If you’re a journalist working on a story and need an expert quote, call us on 0345 092 0807 (out of hours 07702 901 334).

Commenting on latest NICE guidance recommending the use of the Oncotype DX test to help make treatment decisions for patients with early stage breast...

30 September 2013

Commenting on the subcutaneous (SC) injection for Herceptin for patients with HER2-postive breast cancer being granted a license by the European...

24 September 2013

Two of our patient information publications have been recognised by the British Medical Association (BMA) in a prestigious annual awards scheme...

18 September 2013

Commenting on the updated NHS breast screening leaflet and invitation letter in use from today (Monday 16 September 2013) Jackie Harris Clinical...

16 September 2013

Commenting on the decision today (7 August 2013) by the National Institute for Health and Care Excellence (NICE) on guidance for the RD-100i OSNA...

7 August 2013

Commenting on the decision today (6 August 2013) by the National Institute for Health and Clinical Excellence (NICE) not to recommend pertuzumab (...

6 August 2013

Commenting on the decision today (8 July 2013) by the National Institute for Health and Clinical Excellence (NICE) not to recommend everolimus (also...

8 July 2013

Commenting on the new NICE guidance on familial breast cancer: Classification and care of people at risk of familial breast cancer and management...

25 June 2013

Tuesday 14 May 2013 Contact: Sophie Softley Pierce/Sophie Howells sophie.pierce@breastcancercare.org.uk/ sophie.howells@breastcancercare.org.uk...

14 May 2013